event-trade登录编辑
🇺🇸 SECProcter & GambleDoubao · 实盘不做把握 5/10不做原因:其他
北京时间·🕒 发布 19:02:49·⟳ 抓取 19:03:18 +29s·⚡ 决策 10-22 19:11:53 +8m35s·5.2 天前

宝洁FY2027一季度收入、核心EPS与有机销售均超预期,但维持全年核心EPS指引

一季度收入、核心EPS和有机销售均明显高于预期,构成正向业绩惊喜;但全年核心EPS指引未上修且盘前已上涨约2.3%,因此只以小仓、低追价限价单参与,不直接市价追高。

📄 原文Procter & Gamble↗ 原文
----- pg-20261022.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT RE…
不做 The Procter & Gamble Company(PG.US)
[契约校验:LIMIT_AND_CHASE] entry: limit_price 与 max_chase_pct 只能二选一(给了 limit_price 就把 max_chase_pct 置空) 原交易逻辑:Q1收入与EPS双超预期,限价等回落参与业绩漂移
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

宝洁Q1有机销售+4%、核心EPS 2.00美元,均强于市场预期,五大部门有机销售全部为正;不过毛利率同比下滑且全年核心EPS指引仅维持,盘前约2.3%的涨幅已反映大部分惊喜,适合用回调限价小仓参与。

🔎 新鲜度:最早出现 2026-10-22 · 扩散 low · price-in 风险 medium ↗ ↗

消息传播链

  1. 节点
  2. 节点
  3. 节点

关键理由

  • Q1收入232.76亿美元、核心EPS 2.00美元分别高于约228.2亿美元和1.88美元的市场预期,且有机销售+4%高于全年+1%至+3%指引区间。
  • 过去四个同主体盘前业绩样本中,正向业绩后3个交易日胜率为75%、中位涨幅约2.08%,但样本薄,不能支持重仓。

主要风险

  • 核心毛利率同比下降150个基点,公司披露FY2027大宗商品成本税后拖累约14亿美元,盈利指引未上修可能限制涨幅。
  • 盘前5分钟内已升至约160.44美元、较前收盘高约2.3%,若开盘回落或市场视业绩为“见光死”,限价单也可能面临短线浮亏。

反向证据

  • 做多前查反向 · 来源 web · 日期 2026-10-18 · 影响 weakens
    瑞银在业绩前即指出美国消费需求改善但通胀可能压制盈利;公司本次披露核心毛利率同比下滑150个基点、FY2027商品成本税后拖累约14亿美元,且未上修核心EPS指引。
    检索:P&G FY2027 guidance maintained commodity costs margin pressure analyst UBS October 2026 原文 ↗
  • 做多前查反向 · 来源 case_library · 日期 2026-10-22 · 影响 weakens
    自家案例库当日已有多条同财报记录,均因全年有机销售和核心EPS指引维持、缺少上修而未ENTER;该历史倾向提示不能仅凭标题beat追高。
    检索:PG.US FY2027 Q1 earnings no guidance raise 宝洁 不做

先例如何影响了这次决策

对本次决策的影响:确认方向为多,但因样本薄、盘前已接近历史强反应上沿且全年EPS指引未上修,仓位降为small,并设置仅允许较前收盘追价1%的限价。

方向:四个同主体盘前业绩样本3日胜率为75%,正向beat样本通常偏多;但仅去年Q1一条可算高相似且首发锚完全干净。

涨幅量级:全样本1日中位数约-0.13%、3日中位数约+2.08%;强销售beat首日约+2.5%,本次盘前已上涨约2.3%,因此不能把历史3日幅度再加到当前涨幅之上。

形态:弱销售和弱指引样本(2026-07-29)明显高开后持续跑输;正向样本中也存在首日小跌后修复,未见稳定的次日追高暴利模式。

历史先例(按相似度)

  • 相似度 8/10 PG.US 2025-10-22 FY2026 Q1净销售+3%、有机销售+2%、核心EPS 1.99美元,超预期并维持全年指引。 原文 ↗
    事件后 +1日 +0.4% · +2日 +0.4% · +3日 +1.3% · +4日 +0.8% · +5日 +0.5%
    ⚠未核对目标相位 — 该行涨幅别用来定止盈止损
    相似度依据:同一公司、同为10月盘前发布的一财季业绩,且同样为收入和EPS超预期后维持指引。
    经验:去年Q1 beat后首日反应温和,但第3日仍有约1.3%正向漂移,第5日超额收益转负。
  • 相似度 7/10 PG.US 2026-04-24 FY2026 Q3净销售+7%,量驱动有机增长超预期,Zacks当日盘中刊发beat报道。 原文 ↗
    事件后 +1日 +2.5% · +2日 +2.6% · +3日 +3.1% · +4日 +1.3% · +5日 +1.7%
    ⚠来源层级不符(声明issuer/实为media)·未核对目标相位 — 该行涨幅别用来定止盈止损
    相似度依据:同一公司盘前业绩且为量驱动的有机增长超预期,但当季净销售+7%强于本次+4%。
    经验:更强的量驱动beat可带来约2.5%首日反应和3日继续上行。
  • 相似度 6/10 PG.US 2026-01-21 FY2026 Q2业绩盘前发布,首日-0.64%,随后3日累计上涨2.87%。 原文 ↗
    事件后 +1日 -0.6% · +2日 +2.0% · +3日 +2.9% · +4日 +2.4% · +5日 +1.6%
    ⚠来源层级不符(声明issuer/实为media)·未核对目标相位 — 该行涨幅别用来定止盈止损
    相似度依据:同一公司盘前季度财报,但具体超预期幅度和指引内容不同。
    经验:业绩首日小幅下跌后,后续2至3日仍可出现修复,说明单日开盘反应不总是最终方向。
  • 相似度 5/10 PG.US 2026-07-29 FY2026 Q4 EPS超预期但收入不及预期、有机销售0%,全年展望偏弱。 原文 ↗
    事件后 +1日 -1.9% · +2日 -3.3% · +3日 -3.0% · +4日 -2.6% · +5日 -0.6%
    ⚠来源层级不符(声明issuer/实为media)·未核对目标相位 — 该行涨幅别用来定止盈止损
    相似度依据:同一公司盘前财报,但该季收入miss、有机销售0%且指引偏弱,是重要反向样本。
    经验:当销售或指引偏弱时,宝洁这种低波动防御股也会连续数日跑输,不能只因EPS beat做多。
工具执行结果 · 成功 7 · 降级 0 · 失败 0 · 取消 0
  1. search_processed_events 成功 stock_tools HTTP · 6,915 ms
    {"result": "search_processed_events:agent query=`p&g procter gamble q1 fy2027 earnings results | p&g thorne acquisition guidance update commodity headwind | 宝洁 第一财季 业绩 eps 有机销售`;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 72.0/72 小时、26126 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选,不能据此证明消息首发或不是重复;按当前事件继续正常研判。"}
  2. web_search 成功 doubao_search · 1,703 ms
    豆包搜索结果(原始查询:Procter Gamble Q1 fiscal 2027 earnings consensus estimate EPS revenue beat October 22 2026;API SearchType:web)
  3. stock_quote 成功 stock_tools HTTP · 2,003 ms
    {
  4. web_search 成功 doubao_search · 2,525 ms
    豆包搜索结果(原始查询:P&G first quarter 2027 earnings beat analysts expected $1.93 revenue stock rises premarket;API SearchType:web)
  5. web_search 成功 doubao_search · 1,838 ms
    豆包搜索结果(原始查询:Procter Gamble earnings reaction stock January April July 2026 quarterly results shares rose fell;API SearchType:web)
  6. event_study 成功 stock_tools HTTP · 35 ms
    {
  7. search_case_library 成功 stock_tools HTTP · 17 ms
    {"result": "search_case_library「PG.US」—— 与这些标的相关、事件类型=财报/业绩预告的自家决策案例(本页 12 条,该标的全历史相关记录共 64 条;ENTER 只按该标的自己的腿统计):\n◆ PG.US:相关历史决策 64 条 · 其中该标的 ENTER 0 条(0.0%) · 我们从没在这只票上 ENTER 过\n【对所查标的真 ENTER 过的:0 条 —— 相关案例里没有该标的自己的 ENTER 腿】\n【最近 12 条其它决策(多为「不做」,用来看这票最近在被什么消息刷屏)】\n• 2026-10-22 UTC 不做 · 事件:宝洁(Proct

原文全文

展开原文 · 35,749 字
----- pg-20261022.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported)
October 22, 2026
THE
PROCTER & GAMBLE CO
MPANY
(Exact name of registrant as specified in its charter)
Ohio
OH
1-434
31-0411980
(State of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification Number)
One Procter & Gamble Plaza
,
Cincinnati
OH
One Procter & Gamble Plaza
,
Cincinnati
,
Ohio
45202
(Address of principal executive offices)
(Zip Code)
(
513
)
983-1100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
False
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
False
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
False
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
False
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, without Par Value
PG
NYSE
0.110% Notes due 2026
PG26D
NYSE
4.875% EUR notes due May 2027
PG27A
NYSE
1.200% Notes due 2028
PG28
NYSE
3.150% EUR Notes due 2028
PG28B
NYSE
1.250% Notes due 2029
PG29B
NYSE
1.800% Notes due 2029
PG29A
NYSE
6.250% GBP notes due January 2030
PG30
NYSE
0.350% Notes due 2030
PG30C
NYSE
0.230% Notes due 2031
PG31A
NYSE
3.250% EUR Notes due 2031
PG31B
NYSE
5.250% GBP notes due January 2033
PG33
NYSE
2.900% Notes due 2033
PG33B
NYSE
3.200% EUR Notes due 2034
PG34C
NYSE
1.875% Notes due 2038
PG38
NYSE
0.900% Notes due 2041
PG41
NYSE
3.650% Notes due 2045
PG45
NYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
False
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
ITEM 2.02
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On
October 22, 2026
, The Procter & Gamble Company (the "Company") issued a news release with respect to earnings for the quarter ended September 30, 2026. The Company is furnishing this 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition."
ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
Exhibit Number
Description
99.1
News Release by The Procter & Gamble Company dated
October 22, 2026
.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
THE PROCTER & GAMBLE COMPANY
By
/s/ AARON B. SHEPHERD
Aaron B. Shepherd, Assistant Secretary
10/22/2026
EXHIBIT(S)
99.1
News Release by The Procter & Gamble Company dated October 22, 2026
.

----- fy2627q1jas8-kexhibit991.htm -----
EX-99.1
2
fy2627q1jas8-kexhibit991.htm
FY2627 Q1 JAS 8-K EXHIBIT 99.1
Document
News Release
The Procter & Gamble Company
One P&G Plaza
Cincinnati, OH 45202
P&G ANNOUNCES FISCAL YEAR 2027 FIRST QUARTER RESULTS
Net Sales +4.0%; Organic Sales +4.0%
Diluted EPS $1.97, +1%; Core EPS $2.00, +1%
UPDATES NET SALES GUIDANCE FOR THORNE ACQUISITION
MAINTAINS FISCAL YEAR ORGANIC SALES, EPS GROWTH AND CASH RETURN GUIDANCE
CINCINNATI, October 22, 2026 - The Procter & Gamble Company (NYSE:PG) reported first quarter fiscal year 2027 net sales of $23.3 billion, an increase of four percent versus the prior year. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, also increased four percent versus the prior year. Diluted net earnings per share were $1.97, an increase of one percent versus prior year as the increase in net sales was partially offset by an increase in operating costs. Core earnings per share were $2.00, an increase of one percent versus the prior year.
Operating cash flow was $5.8 billion, and net earnings were $4.8 billion for the quarter. Free cash flow productivity was 93%. Free cash flow productivity is calculated as operating cash flow less capital spending, as a percentage of net earnings. The Company returned $3.9 billion of cash to shareowners via $2.6 billion of dividend payments and $1.3 billion of share repurchases.
First Quarter ($ billions, except EPS)
GAAP
2027
2026
% Change
Non-GAAP*
2027
2026
% Change
Net Sales
23.3
22.4
4.0%
Organic Sales
n/a
n/a
4.0%
Diluted EPS
1.97
1.95
1%
Core EPS
2.00
1.99
1%
*Please refer to Exhibit 1 - Non-GAAP Measures for the definition and reconciliation of these measures to the related GAAP measures.
“Our solid sales, earnings and cash results in the first quarter reflect sharpened execution of our integrated strategy” said Shailesh Jejurikar, Chairman of the Board, President and Chief Executive Officer. “While we expect there will continue to be geopolitical and economic challenges, this strong start keeps us on track to deliver within our guidance ranges for organic sales growth, core EPS growth and free cash flow productivity for the fiscal year. We remain committed to our strategy to delight consumers with superior products at a superior value by putting the consumer first in everything we do. We are confident in the near term and excited about the future.”
July - September Quarter Discussion
Net sales in the first quarter of fiscal year 2027 were $23.3 billion, a four percent increase versus the prior year. Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, also increased four percent driven by a two percent increase from volume and a one percent increase from favorable mix. Pricing had a minor positive impact on sales for the quarter.
July - September 2026
Volume
Foreign Exchange
Price
Mix
A&D
(2)
Net Sales
Organic Volume
Organic Sales
Net Sales Drivers
(1)
Beauty
2.2%
1.1%
0.7%
2.5%
—%
6.4%
2.2%
5.4%
Grooming
(0.4)%
(0.4)%
3.5%
1.5%
(0.1)%
4.0%
(0.4)%
4.5%
Health Care
(2.9)%
0.4%
2.8%
2.8%
(0.1)%
3.1%
(2.9)%
2.7%
Fabric & Home Care
4.3%
(0.6)%
(0.3)%
0.8%
—%
4.2%
4.3%
4.8%
Baby, Feminine & Family Care
2.3%
(0.1)%
(1.2)%
1.8%
—%
2.9%
2.3%
3.0%
Total P&G
2.4%
—%
0.4%
1.1%
—%
4.0%
2.4%
4.0%
(1)
Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2)
Acquisitions and Divestitures excluding volume impact.
•
Beauty segment organic sales increased five percent versus year ago. Hair Care organic sales increased mid-single digits driven by innovation-based pricing in North America and Latin America, favorable product mix and an increase in unit volume. Personal Care organic sales increased mid-single digits driven by volume growth in Greater China and Europe and favorable product mix, partially offset by trade investments. Skin Care organic sales increased mid-single digits due to favorable premium product mix and a unit volume increase in North America.
•
Grooming segment organic sales increased five percent versus year ago driven by innovation-based pricing, primarily in North America and IMETA, and favorable product mix.
•
Health Care segment organic sales increased three percent versus year ago. Oral Care organic sales increased low single digits driven by premium product mix and innovation-based pricing, partially offset by a unit volume decline. Personal Health Care organic sales increased low single digits due to higher pricing, primarily in North America and Latin America, and favorable product mix, partially offset by a unit volume decline.
•
Fabric and Home Care segment organic sales increased five percent versus year ago. Fabric Care organic sales increased mid-single digits driven by volume increases in North America and Europe and favorable geographic mix. Home Care organic sales also increased mid-single digits driven by volume increases in North America and Europe and favorable product mix.
•
Baby, Feminine and Family Care segment organic sales increased three percent versus year ago. Baby Care organic sales increased mid-single digits driven by a unit volume increase, primarily in Greater China and North America, and favorable premium product mix, partially offset by lower pricing, primarily in North America. Feminine Care organic sales increased low single digits driven by favorable product mix and innovation-based pricing, primarily in North America, partially offset by a unit volume decline in Europe. Family Care organic sales increased low single digits driven by a unit volume increase, partially offset by merchandising investments.
Diluted net earnings per share increased by one percent to $1.97. Core earnings per share increased one percent to $2.00 and Currency-neutral Core EPS was unchanged versus the prior year.
Reported gross margin for the quarter decreased 160 basis points versus the prior year. Core gross margin and currency-neutral Core gross margin for the quarter decreased 150 basis points versus the prior year and excluded the impact from incremental restructuring charges. The decrease was driven by 140 basis points of higher costs from commodities, 140 basis points of product reinvestments, 50 basis points of unfavorable mix and 10 basis points of rounding and other items, partially offset by 120 basis points of gross productivity savings, 50 basis points of tariff impact from lower costs and recognized recoveries and 20 basis points of increased pricing.
Reported selling, general and administrative expense (SG&A) as a percentage of sales declined 90 basis points versus year ago. Core SG&A as a percentage of sales decreased 80 basis points versus year ago and decreased 70 basis points on a currency-neutral basis. Core SG&A excluded the impact from incremental restructuring charges. The decline was driven by 130 basis points of productivity savings and 100 basis points of net sales growth leverage, partially offset by 120 basis points of reinvestments and 40 basis points of rounding and other items.
Reported operating margin for the quarter decreased 70 basis points versus the prior year. Excluding the impact of non-core restructuring charges, core operating margin decreased 80 basis points versus the prior year and decreased 90 basis points on a currency-neutral basis. Core operating margin included gross productivity savings of 250 basis points.
Fiscal Year 2027 Guidance
P&G updated its guidance range for fiscal 2027 all-in sales growth to be in the range of two to four percent versus the prior year, reflecting the acquisition of Thorne as of October 1, 2026. The Company maintained its outlook for organic sales growth in the range of one to three percent versus the prior year.
Included in the organic sales growth guidance is a headwind of 30 to 50 basis points from brand, product form and go-to-market discontinuations.
P&G maintained its fiscal 2027 diluted net earnings per share growth to be in the range of one to five percent versus fiscal 2026 diluted net EPS of $6.62. P&G also maintained its fiscal 2027 core earnings per share growth to be in the range of in-line to three percent versus fiscal 2026 core EPS of $6.89. This outlook equates to a range of $6.89 to $7.11 per share, with a mid-point estimate of $7.00, or an increase of approximately one and a half percent.
P&G now expects a commodity cost headwind of approximately $1.4 billion after tax driven by higher raw materials, energy and transportation costs, $300 million after-tax from higher net interest expense, $150 million after-tax from lower non-operating income and $50 million after-tax from unfavorable foreign exchange rates. Combined, these impacts equate to a headwind of $0.79 per share for fiscal 2027, or an eleven percent drag on core EPS growth.
The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures without unreasonable efforts given the unpredictability of the timing and amounts of discrete items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results.
P&G now expects a core effective tax rate to be in the range of 20% to 21% in fiscal 2027.
Capital spending is estimated to be in the range of four and a half to five and a half percent of fiscal 2027 net sales.
P&G continues to expect free cash flow productivity of 85% to 90% and expects to pay over $10 billion in dividends and to repurchase approximately $5 billion of common shares in fiscal 2027.
Forward-Looking Statements
Certain statements in this release, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result" and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange or pricing controls and tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, conflicts or acts of war, terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pensions and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, cyber incidents, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers,
distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage demand, supply and operational challenges; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving and more fragmented digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions.
For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 65 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.
#    #    #
P&G Media Contacts
:
Wendy Kennedy, 513.780.7212
Holly Stutz Smith, 513.659.9949
P&G Investor Relations Contact
:
Keri Cowan, 513.983.2414
Category: PG-IR
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Consolidated Earnings Information
Three Months Ended September 30
Amounts in millions except per share amounts
2026
2025
% Chg
NET SALES
$
23,276
$
22,386
4%
Cost of products sold
11,678
10,887
7%
GROSS PROFIT
11,598
11,499
1%
Selling, general and administrative expense
5,661
5,643
—%
OPERATING INCOME
5,937
5,856
1%
Interest expense
(223)
(197)
13%
Interest income
102
108
(6)%
Other operating income/(expense), net
207
268
(23)%
EARNINGS BEFORE INCOME TAXES
6,023
6,034
—%
Income taxes
1,267
1,253
1%
NET EARNINGS
4,757
4,781
(1)%
Less: Net earnings attributable to noncontrolling interests
26
31
(16)%
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
$
4,731
$
4,750
—%
EFFECTIVE TAX RATE
21.0
%
20.8
%
NET EARNINGS PER COMMON SHARE
(1)
Basic
$
2.00
$
2.00
—%
Diluted
$
1.97
$
1.95
1%
DIVIDENDS PER COMMON SHARE
$
1.0885
$
1.0568
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
2,407.2
2,436.8
COMPARISONS AS A % OF NET SALES
Basis Pt Chg
Gross profit
49.8%
51.4%
(160)
Selling, general and administrative expense
24.3%
25.2%
(90)
Operating income
25.5%
26.2%
(70)
Earnings before income taxes
25.9%
27.0%
(110)
Net earnings
20.4%
21.4%
(100)
Net earnings attributable to Procter & Gamble
20.3%
21.2%
(90)
(1)
Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
Certain columns and rows may not add due to rounding.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Consolidated Earnings Information
Three Months Ended September 30, 2026
Amounts in millions
Net Sales
% Change Versus Year Ago
Earnings/(Loss) Before Income Taxes
% Change Versus Year Ago
Net Earnings/(Loss)
% Change Versus Year Ago
Beauty
$
4,410
6%
$
1,139
1%
$
868
(1)%
Grooming
1,889
4%
619
6%
477
3%
Health Care
3,318
3%
1,029
10%
783
9%
Fabric & Home Care
8,205
4%
2,080
4%
1,601
3%
Baby, Feminine & Family Care
5,322
3%
1,390
(4)%
1,060
(4)%
Corporate
132
N/A
(234)
N/A
(32)
N/A
Total Company
$
23,276
4%
$
6,023
—%
$
4,757
(1)%
Three Months Ended September 30, 2026
Net Sales Drivers
(1)
Volume
Organic Volume
Foreign Exchange
Price
Mix
A&D
(2)
Net Sales
Beauty
2.2%
2.2%
1.1%
0.7%
2.5%
—%
6.4%
Grooming
(0.4)%
(0.4)%
(0.4)%
3.5%
1.5%
(0.1)%
4.0%
Health Care
(2.9)%
(2.9)%
0.4%
2.8%
2.8%
(0.1)%
3.1%
Fabric & Home Care
4.3%
4.3%
(0.6)%
(0.3)%
0.8%
—%
4.2%
Baby, Feminine & Family Care
2.3%
2.3%
(0.1)%
(1.2)%
1.8%
—%
2.9%
Total Company
2.4%
2.4%
—%
0.4%
1.1%
—%
4.0%
(1)
Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2)
Acquisitions and Divestitures excluding volume impact.
Certain columns and rows may not add due to rounding.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Three Months Ended September 30
Amounts in millions
2026
2025
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD
$
9,942
$
9,556
OPERATING ACTIVITIES
Net earnings
4,757
4,781
Depreciation and amortization
810
761
Share-based compensation expense
98
121
Deferred income taxes
115
53
(Gain)/loss on sale of assets
(20)
(3)
Change in accounts receivable
(589)
(305)
Change in inventories
(349)
(303)
Change in accounts payable
1,149
648
Other
(204)
(344)
TOTAL OPERATING ACTIVITIES
5,767
5,408
INVESTING ACTIVITIES
Capital expenditures
(1,366)
(1,200)
Proceeds from asset sales
27
8
Acquisitions, net of cash acquired
—
(5)
Other investing activity
(121)
(338)
TOTAL INVESTING ACTIVITIES
(1,460)
(1,535)
FINANCING ACTIVITIES
Dividends to shareholders
(2,603)
(2,549)
Additions to short-term debt with original maturities of more than three months
—
1,123
Reductions in short-term debt with original maturities of more than three months
(157)
(1,800)
Net additions/(reductions) to other short-term debt
5,758
2,108
Reductions in long-term debt
(747)
(3)
Treasury stock purchases
(1,250)
(1,250)
Impact of stock options and other
143
134
TOTAL FINANCING ACTIVITIES
1,144
(2,239)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
(29)
(20)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
5,423
1,615
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD
$
15,365
$
11,171
Certain columns and rows may not add due to rounding.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
Amounts in millions
September 30, 2026
June 30, 2026
Cash and cash equivalents
$
15,365
$
9,942
Accounts receivable
6,620
6,056
Inventories
8,485
8,170
Prepaid expenses and other current assets
2,038
2,040
TOTAL CURRENT ASSETS
32,508
26,208
Property, plant and equipment, net
25,519
25,360
Goodwill
41,197
41,276
Trademarks and other intangible assets, net
21,359
21,444
Other noncurrent assets
12,549
12,231
TOTAL ASSETS
$
133,132
$
126,521
Accounts payable
$
17,056
$
16,306
Accrued and other liabilities
10,911
11,091
Debt due within one year
17,028
11,296
TOTAL CURRENT LIABILITIES
44,996
38,694
Long-term debt
21,897
22,842
Deferred income taxes
5,949
5,760
Other noncurrent liabilities
4,954
4,914
TOTAL LIABILITIES
77,795
72,210
TOTAL SHAREHOLDERS' EQUITY
55,337
54,311
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
$
133,132
$
126,521
Certain columns and rows may not add due to rounding.
The Procter & Gamble Company
Exhibit 1: Non-GAAP Measures
The following provides definitions of the non-GAAP measures used in Procter & Gamble's October 22, 2026 earnings release and the reconciliation to the most closely related GAAP measures. We believe that these measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of period-to-period results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measures but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.
The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results. Note that certain columns and rows may not add due to rounding.
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following item:
•
Incremental restructuring:
The Company has historically had an ongoing level of restructuring activities of approximately $250 - $500 million before tax annually. In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $2 billion in before-tax restructuring costs over two years and has incurred over half of the costs under this plan in fiscal 2026, with the remainder expected to be incurred in fiscal 2027. The adjustments to Core earnings include the restructuring charges that exceed the normal, recurring level of restructuring charges.
We do not view the above item to be part of our sustainable results, and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.
Organic sales growth
: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by
providing sales growth on a consistent basis. This measure is used in assessing the achievement of management goals for at-risk compensation.
Core EPS and Currency-neutral Core EPS:
Core earnings per share, or Core EPS, is a measure of diluted net earnings per common share (diluted EPS) adjusted for items as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange. Management views these non-GAAP measures as useful supplemental measures of Company performance over time.
Core gross margin and Currency-neutral Core gross margin
: Core gross margin is a measure of the Company's gross margin adjusted for items as indicated. Currency-neutral Core gross margin is a measure of the Company's Core gross margin excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company’s operating efficiency over time.
Core selling, general and administrative (SG&A) expense as a percentage of sales and Currency-neutral Core SG&A expense as a percentage of sales
: Core SG&A expense as a percentage of sales is a measure of the Company's selling, general and administrative expense as a percentage of net sales adjusted for items as indicated. Currency-neutral Core SG&A expense as a percentage of sales is a measure of the Company's Core selling, general and administrative expense as a percentage of net sales excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company's operating efficiency over time.
Core operating margin and Currency-neutral Core operating margin
: Core operating margin is a measure of the Company's operating margin adjusted for items as indicated. Currency-neutral Core operating margin is a measure of the Company's Core operating margin excluding the incremental current year impact of foreign exchange. Management believes these non-GAAP measures provide a supplemental perspective to the Company’s operating efficiency over time.
Free cash flow
: Free cash flow is defined as operating cash flow less capital spending. Free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. We view free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.
Free cash flow productivity
: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. We view free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Free cash flow productivity is used by management in making operating decisions, in allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation.
Certain columns and rows may not add due to rounding.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Three Months Ended September 30, 2026
Amounts in millions except per share amounts
As Reported (GAAP)
Incremental Restructuring
Core
(Non-GAAP)
Cost of products sold
$
11,678
$
(44)
$
11,634
Gross profit
11,598
44
11,642
Gross margin
49.8
%
0.2
%
50.0
%
Currency impact to Core gross margin
—
%
Currency-neutral Core gross margin
50.0
%
Selling, general and administrative expense
5,661
(54)
5,607
Selling, general and administrative expense as a % of net sales
24.3
%
(0.2)
%
24.1
%
Currency impact to Core selling, general and administrative expense as a % of net sales
0.1
%
Currency-neutral Core selling, general and administrative expense as a % of net sales
24.2
%
Operating income
5,937
98
6,035
Operating margin
25.5
%
0.4
%
25.9
%
Currency impact to Core operating margin
(0.1)
%
Currency-neutral Core operating margin
25.8
%
Other non-operating income/(expense), net
207
2
209
Income taxes
1,267
20
1,287
Net earnings
4,757
80
4,837
Less: Net earnings attributable to noncontrolling interests
26
2
28
Net earnings attributable to P&G
4,731
77
4,808
Core EPS
Diluted net earnings per common share
(1)
$
1.97
$
0.03
$
2.00
Currency impact to Core EPS
$
(0.01)
Currency-neutral Core EPS
$
1.99
Diluted weighted average common shares outstanding
2,407.2
(1)
Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Three Months Ended September 30, 2025
Amounts in millions except per share amounts
As Reported (GAAP)
Incremental Restructuring
Core
(Non-GAAP)
Cost of products sold
$
10,887
$
(39)
$
10,848
Gross profit
11,499
39
11,537
Gross margin
51.4
%
0.1
%
51.5
%
Currency impact to Core gross margin
0.2
%
Currency-neutral Core gross margin
51.7
%
Selling, general and administrative expense
5,643
(77)
5,566
Selling, general and administrative expense as a % of net sales
25.2
%
(0.3)
%
24.9
%
Currency impact to Core selling, general and administrative expense as a % of net sales
0.3
%
Currency-neutral Core selling, general and administrative expense as a % of net sales
24.6
%
Operating income
5,856
116
5,972
Operating margin
26.2
%
0.5
%
26.7
%
Currency impact to Core operating margin
0.4
%
Currency-neutral Core operating margin
27.1
%
Other non-operating income/(expense), net
268
7
275
Income taxes
1,253
23
1,276
Net earnings attributable to P&G
4,750
100
4,850
Core EPS
Diluted net earnings per common share
(1)
$
1.95
$
0.04
$
1.99
Currency impact to earnings
$
—
Currency-neutral EPS
$
1.99
Diluted weighted average common shares outstanding
2,436.8
(1)
Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE VERSUS YEAR AGO
Gross margin
(160)
BPS
Core gross margin
(150)
BPS
Currency-neutral Core gross margin
(150)
BPS
Selling, general and administrative expense as a % of net sales
(90)
BPS
Core selling, general and administrative expense as a % of net sales
(80)
BPS
Currency-neutral Core selling, general and administrative as a % of net sales
(70)
BPS
Operating margin
(70)
BPS
Core operating margin
(80)
BPS
Currency-neutral Core operating margin
(90)
BPS
Diluted EPS
1
%
Core EPS
1
%
Currency-neutral Core EPS
—
%
Certain columns and rows may not add due to rounding.
Organic sales growth
:
July - September 2026
Net Sales Growth
Foreign Exchange Impact
Acquisition & Divestiture Impact
Organic Sales Growth
Beauty
6.4%
(1.1)%
—%
5.4%
Grooming
4.0%
0.4%
0.2%
4.5%
Health Care
3.1%
(0.4)%
—%
2.7%
Fabric & Home Care
4.2%
0.6%
—%
4.8%
Baby, Feminine & Family Care
2.9%
0.1%
—%
3.0%
Total Company
4.0%
—%
—%
4.0%
Total Company
Net Sales Growth
Combined Foreign Exchange & Acquisition/Divestiture Impact/Other
(1)
Organic Sales Growth
FY 2027 (Estimate)
+2% to +4%
-1%
+1% to +3%
(1)
Combined Foreign Exchange & Acquisition/Divestiture Impact/Other includes foreign exchange impacts, the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Core EPS growth
:
Total Company
Diluted EPS Growth
Impact of Incremental Non-Core Items
(1)
Core EPS Growth
FY 2027 (Estimate)
+1% to +5%
-1% to -2%
-% to +3%
(1)
Includes the impact of incremental non-core restructuring charges including the portfolio and productivity plan.
Free cash flow (dollar amounts in millions)
:
Three Months Ended September 30, 2026
Operating Cash Flow
Capital Spending
Free Cash Flow
$5,767
$(1,366)
$4,401
Free cash flow productivity (dollar amounts in millions)
:
Three Months Ended September 30, 2026
Free Cash Flow
Net Earnings
Free Cash Flow Productivity
$4,401
$4,757
93%
Certain columns and rows may not add due to rounding.

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

  1. 2ad9e9b54f · 2026-10-22 19:11 · doubao / doubao-seed-evolving-latest-version · 策略包 658c0c1e2ba5当前